Liu, Xiaohan
Tian, Wei
Dai, Anli
Li, Hui
Zhu, Mei
Zeng, Mengsi
Feng, Ronghua
Zhang, Zhenyu
Jiang, Xiaosong
Wen, Yu
Wu, Tao
Xiao, Zemin
Funding for this research was provided by:
the Science and Technology Innovation Program of Hunan Province (2017SK51302)
the Clinical Medical Technology Demonstration Base For Precise Radiotherapy In Hunan Province (2020SK4021)
Article History
Received: 2 July 2024
Accepted: 31 December 2024
First Online: 10 January 2025
Declarations
:
: The authors declare no competing interests.
: The study involving human participants were reviewed and approved by the Institutional Review Board of the First People’s Hospital of Changde City, China. The ethics approval ID is YX-2024–004-01. All authors confirmed that all experiments were performed in accordance with relevant guidelines and regulations.
: This is an observational study, which does not pose risks to the subjects in terms of examination or treatment. The study was conducted in strict compliance with local laws and regulations, and informed consent was waived with the approval of the Ethics Committee.